LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 1, 2009, Pages

  Minter, Rebecca M ^a,c   Bi, Xiaoming ^a   Ben Josef, Gal ^a   Wang, Tianyi ^a   Hu, Bin ^a   Arbabi, Saman ^a   Hemmila, Mark R ^a   Wang, Stewart C ^a   Remick, Daniel G ^a   Su, Grace L ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Veterans Administration Ann Arbor Healthcare Systems   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chemokines; Common bile duct ligation; Cytokines; Kupffer cells

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN LIX; PROTEIN TNFSR1; PROTEIN TNFSR2; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; CHOLESTASIS; FEMALE; KUPFFER CELL; LIVER INJURY; MEDIATOR RELEASE; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 58249105899     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00041.2008     Document Type: Article

References (46)

1. Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 363: 1608-1610, 2004.
2. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37: 208-217, 2003.
3. Arana M de J, Vallespi MG, Chinea G, Vallespi GV, Rodriguez-Alonso I, Garay HE, Buurman WA, Reyes O. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. J Endotoxin Res 9: 281-291, 2003.
4. Blamey SL, Fearon KC, Gilmour WH, Osborne DH, Carter DC. Prediction of risk in biliary surgery. Br J Surg 70: 535-538, 1983.
5. Copeland S, Siddiqui J, Remick D. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J Immunol Methods 284: 99 -106, 2004.
6. Dixon JM, Armstrong CP, Duffy SW, Davies GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24: 845-852, 1983.
7. Fierer J, Swancutt MA, Heumann D, Golenbock D. The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice. J Immunol 168: 6396-6403, 2002.
8. Froon AH, Dentener MA, Greve JW, Ramsay G, Buurman WA. Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis 171: 1250-1257, 1995.
9. Fujiwara Y, Shimada M, Yamashita Y, Adachi E, Shirabe K, Takenaka K, Sugimachi K. Cytokine characteristics of jaundice in mouse liver. Cytokine 13: 188-191, 2001.
10. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 270: 5320-5325, 1995.
11. Gutsmann T, Haberer N, Carroll SF, Seydel U, Wiese A. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes. Biol Chem 382: 425-434, 2001.
12. Gutsmann T, Muller M, Carroll SF, MacKenzie RC, Wiese A, Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 69: 6942-6950, 2001.
13. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179: 269-277, 1994.
14. Harry D, Anand R, Holt S, Davies S, Marley R, Fernando B, Goodier D, Moore K. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology 30: 1198-1205, 1999.
15. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 323: 59 -72, 2002.
16. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg M, Schmitz G, Stelter F, Schutt C. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389: 742-745, 1997.
17. Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, Halliday MI, Rowlands BJ. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg 86: 628-633, 1999.
18. Kennedy JA, Lewis H, Clements WD, Kirk SJ, Campbell G, Halliday MI, Rowlands BJ. Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg 86: 1410-1414, 1999.
19. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 46: 725-731, 2000.
20. Kimmings AN, van Deventer SJ, Rauws EAJ, Huibregtse K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur J Surg 166: 700-705, 2000.
21. Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, Nagakawa K, Ambiru S, Shimizu H, Yoshitome H. Anti-inflammatory response in patients with obstructive jaundice caused by biliary malignancy. J Gastroenterol Hepatol 16: 467-472, 2001.
22. Knook DL, Sleyster EC. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 99: 444-449, 1976.
23. Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, Schumann RR. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 101: 2065-2071, 1998.
24. Lazar G Jr, Paszt A, Kaszaki J, Duda E, Szakacs J, Tiszlavicz L, Boros M, Balogh A, Lazar G. Kupffer cell phagocytosis blockade decreases morbidity in endotoxemic rats with obstructive jaundice. Inflamm Res 51: 511-518, 2002.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
26. Minter RM, Fan MH, Sun J, Niederbichler A, Ipaktchi K, Arbabi S, Hemmila MR, Remick DG, Wang SC, Su GL. Altered Kupffer cell function in biliary obstruction. Surgery 138: 236-245, 2005.
27. Nomura T, Shirai Y, Hatakeyama K. Impact of bactibilia on the development of postoperative abdominal septic complications in patients with malignant biliary obstruction. Int Surg 84: 204-208, 1999.
28. O'Neil S, Hunt J, Filkins J, Gamelli R. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-alpha and systemic and tissue tumor necrosis factor-alpha levels after endotoxin. Surgery 122: 281-286; discussion 286-287, 1997.
29. Pertoft H, Smedsrod B. Separation and characterization of liver cells; In: Cell Separation: Methods and Selected Applications, edited by Pretlow TP. New York: Academic, 1987, p. 1-24.
30. Pitt HA, Cameron JL, Postier RG, Gadacz TR. Factors affecting mortality in biliary tract surgery. Am J Surg 141: 66 -72, 1981.
31. Roes S, Mumm F, Seydel U, Gutsmann T. Localization of the lipopolysaccharide-binding protein in phospholipid membranes by atomic force microscopy. J Biol Chem 281: 2757-2763, 2006.
32. Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16: 3490-3503, 1996.
33. Su CH, P' eng FK, Lui WY. Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 16: 536-540, 1992.
34. Su GL, Gong KQ, Fan MH, Kelley WM, Hsieh J, Sun JM, Hemmila MR, Arbabi S, Remick DG, Wang SC. Lipopolysaccharide-binding protein modulates acetaminophen-induced liver injury in mice. Hepatology 41: 187-195, 2005.
35. Su GL, Goyert SM, Fan MH, Aminlari A, Gong KQ, Klein RD, Myc A, Alarcon WH, Steinstraesser L, Remick DG, Wang SC. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Am J Physiol Gastrointest Liver Physiol 283: G640-G645, 2002.
36. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, Remick DG, Wang SC. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 31: 932-936, 2000.
37. Thompson JN, Edwards WH, Winearls CG, Blenkharn JI, Benjamin IS, Blumgart LH. Renal impairment following biliary tract surgery. Br J Surg 74: 843-847, 1987.
38. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 270: 10482-10488, 1995.
39. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164: 777-793, 1986.
40. Welborn MB 3rd, Douglas WG, Abouhamze Z, Auffenburg T, Abouhamze AS, Baumhofer J, Seeger JM, Pruitt JH, Edwards PD, Chizzonite R, Martin D, Moldawer LL, Harward TR. Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse. Shock 6: 171-176, 1996.
41. White JS, Hoper M, Parks RW, Clements WD, Diamond T. Patterns of bacterial translocation in experimental biliary obstruction. J Surg Res 132: 80-84, 2006.
42. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990.
43. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180: 1025-1035, 1994.
44. Wurfel MM, Monks BG, Ingalls RR, Dedrick RL, Delude R, Zhou D, Lamping N, Schumann RR, Thieringer R, Fenton MJ, Wright SD, Golenbock D. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 186: 2051-2056, 1997.
45. Yang KK, Dorner BG, Merkel U, Ryffel B, Schutt C, Golenbock D, Freeman MW, Jack RS. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J Immunol 169: 4475-4480, 2002.
46. Yu B, Wright SD. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J Biol Chem 271: 4100-4105, 1996.